Last reviewed: September 10, 2026
Last updated: September 10, 2026
Written by: Jay Hastings, CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.
Medically reviewed by: Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.
The short answer
Amble and PlexusDx both offer flat monthly pricing for compounded GLP-1 injections with no membership fees, no hidden costs, and month-to-month billing. Amble prices compounded semaglutide with a first-month advertised rate of $179 and ongoing refills at $199/month, and compounded tirzepatide in two tiers: $289/month for starter doses (2.5–5 mg) and $329/month for higher doses (7.5–15 mg). PlexusDx prices compounded semaglutide at $189/month and compounded tirzepatide at a single flat rate of $289/month regardless of dose. Over 12 months, Amble's semaglutide costs $2,398 ($179 first month + eleven refills at $199) versus PlexusDx's $2,268—a $130 difference favoring PlexusDx. Low-dose tirzepatide costs $3,468 at both providers. High-dose tirzepatide costs $3,948 at Amble versus $3,468 at PlexusDx—a $480 advantage for PlexusDx. PlexusDx also offers 3-month and 6-month commitment pricing that lowers per-month rates further, and provides oral formulations and a microdose maintenance option not available at Amble. The better choice depends on whether you prioritize the lowest semaglutide cost or flat tirzepatide pricing as you titrate.
Exploring flat-rate GLP-1 options with transparent monthly billing?
Compare all PlexusDx weight-management protocols, including multi-month commitment pricing and oral formulations.
View All Weight-Management Protocols →
At-a-glance comparison
| Feature |
Amble |
PlexusDx |
| Semaglutide injection (MTM) |
$179 first month, $199/month refill |
$189/month |
| Tirzepatide injection low-dose (MTM) |
$289/month (2.5–5 mg) |
$289/month (all doses) |
| Tirzepatide injection high-dose (MTM) |
$329/month (7.5–15 mg) |
$289/month (all doses) |
| Membership fee |
$0 |
$0 |
| Billing model |
Monthly, no prepay |
Monthly, 3-mo, or 6-mo commitment |
| Oral formulations |
No |
Semaglutide $289/mo MTM; tirzepatide $349/mo MTM |
| Maintenance/microdose option |
Not advertised |
Microdose GLP-1 $129/month MTM |
| Trustpilot rating |
Not available in captured evidence |
4.3 stars (79% five-star, 83% four-star or higher) |
Evidence note: Amble pricing was captured from the provider's published FAQ (hosted on Canva) on September 4, 2026. The figures represent Amble's own advertised rates but were not validated at checkout. PlexusDx pricing reflects standard published rates as of September 10, 2026, with month-to-month rates confirmed in July 2026 site captures.
Like-for-like monthly pricing breakdown
Both Amble and PlexusDx use month-to-month billing with no prepay requirement at the baseline tier. Amble advertises a first-month rate for semaglutide with a higher ongoing refill rate; PlexusDx maintains a single flat rate throughout treatment.
Compounded semaglutide injection
-
Amble: $179 first month, $199/month ongoing refill rate at all doses
-
PlexusDx: $189/month at all doses (month-to-month); $169/month on 3-month commitment; $149/month on 6-month commitment
-
12-month cost (MTM): Amble $2,398 ($179 + 11 × $199); PlexusDx $2,268 (our calculation)
-
Difference: PlexusDx is $130 lower over 12 months
Amble's first-month advertised rate of $179 is $10 lower than PlexusDx's flat $189, but the ongoing $199 refill rate means PlexusDx's single flat rate saves $130 over a full year. PlexusDx's 6-month commitment rate ($149/month, or $1,788 over 12 months prepaid per-month calculation—our calculation) offers further savings, but that comparison crosses billing-model boundaries: Amble does not publish a multi-month prepaid option in the available evidence.
Compounded tirzepatide injection: low-dose tier
-
Amble: $289/month for 2.5–5 mg doses
-
PlexusDx: $289/month at all doses (month-to-month); $269/month on 3-month commitment; $249/month on 6-month commitment
-
12-month cost (MTM): Both $3,468 (our calculation)
-
Difference: Equal at month-to-month baseline
At starter tirzepatide doses, Amble and PlexusDx charge identical month-to-month rates. PlexusDx's commitment pricing ($269 or $249/month) again offers a lower effective rate for patients willing to prepay.
Compounded tirzepatide injection: high-dose tier
-
Amble: $329/month for 7.5–15 mg doses
-
PlexusDx: $289/month at all doses (month-to-month)
-
12-month cost (MTM): Amble $3,948; PlexusDx $3,468 (our calculation)
-
Difference: PlexusDx is $480 lower over 12 months, or $40/month
Amble's two-tier tirzepatide pricing creates a $40/month gap at higher doses. PlexusDx maintains a single flat rate regardless of titration, which produces a clear advantage for patients on maintenance doses above 5 mg.
See if you qualify for flat-rate semaglutide or tirzepatide
A licensed provider reviews your intake and determines whether a prescription is appropriate for you.
Start My 60-Second Intake →About 60 seconds · $0 charged until provider approval.
Decision factors beyond the per-month rate
Dose-tier structure and titration
Amble's two-tier tirzepatide model mirrors cost structure at some other compounded providers: lower monthly cost during titration, higher cost at maintenance. PlexusDx's single flat rate simplifies budgeting and eliminates a price jump mid-treatment. For semaglutide, both providers charge one flat rate at all doses.
Commitment discounts and prepay options
PlexusDx offers 3-month and 6-month commitment pricing that lowers the effective monthly rate: semaglutide drops to $149/month on a 6-month plan, and tirzepatide to $249/month. Amble's pricing in the captured evidence is month-to-month only; no multi-month prepay figures were published. Patients who prefer to lock in a lower rate and are confident in multi-month adherence may favor PlexusDx's commitment tiers; those who want maximum month-to-month flexibility will appreciate Amble's baseline semaglutide rate.
Medication variety
Amble advertises compounded semaglutide and tirzepatide injections only. PlexusDx offers the same two injections plus oral semaglutide capsules ($289/month month-to-month), oral tirzepatide capsules ($349/month month-to-month), and a microdose GLP-1 maintenance protocol ($129/month). Patients interested in needle-free administration or a lower-cost maintenance option have those choices at PlexusDx; they are not advertised at Amble in the available evidence.
Review record and service transparency
PlexusDx holds a 4.3-star rating on Trustpilot, with 79% of reviews at five stars and 83% at four stars or higher (captured September 9, 2026; trustpilot.com/review/plexusdx.com). Amble's Trustpilot and Reddit presence was indexed in the research but rating, volume, and thematic review data were not captured, so a side-by-side service-quality comparison is not supported by the available evidence.
Choose Amble if…
- You are starting tirzepatide and expect to remain at or below 5 mg, where Amble matches PlexusDx at $289/month.
- You strongly prefer true month-to-month billing with no multi-month commitment decision to evaluate.
Choose PlexusDx if…
- You want compounded semaglutide injection and prefer a lower total annual cost—PlexusDx saves $130 over 12 months versus Amble's first-month-plus-refill pricing.
- You are on or plan to titrate to higher tirzepatide doses (7.5 mg or above), where PlexusDx's flat $289/month saves $40/month versus Amble's $329 high-dose tier.
- You want access to oral semaglutide, oral tirzepatide, or a microdose GLP-1 maintenance protocol not advertised at Amble.
- You are willing to commit to 3 or 6 months to capture lower effective monthly rates ($149/month semaglutide or $249/month tirzepatide on the 6-month plan).
- You value a documented Trustpilot review record (4.3 stars, 83% four-star or higher) as part of your provider-selection research.
Methodology and freshness
Amble pricing was captured from the provider's FAQ page (hosted on Canva) on September 4, 2026. The figures reflect Amble's published rates but were not validated at live checkout; readers should confirm final pricing during their own enrollment. PlexusDx month-to-month rates ($189 semaglutide, $289 tirzepatide) were confirmed in site captures from July 17–23, 2026, and re-validated September 10, 2026. Multi-month commitment rates ($169/$149 semaglutide, $269/$249 tirzepatide) and oral/microdose pricing are programmatic and current as of September 10, 2026. All 12-month cost totals and prepaid per-month calculations are our calculation. PlexusDx Trustpilot data (4.3 stars, 79% five-star, 83% four-star or higher) was captured September 9, 2026, from trustpilot.com/review/plexusdx.com. Amble's semaglutide first-month rate is $179, with ongoing refills at $199/month; no promotional or introductory pricing was identified for tirzepatide at either provider in the research packet. Both providers dispense compounded medications; see the disclosure at the end of this article.
Frequently Asked Questions
Does Amble charge a membership fee or hidden costs?
No. Amble advertises $0 membership fee and no hidden or shipping fees. The published per-month medication rate ($179 first month then $199 ongoing for semaglutide; $289 or $329 tirzepatide) is described as all-inclusive with monthly billing and no prepay requirement.
Why does Amble price tirzepatide in two tiers?
Amble charges $289/month for tirzepatide doses between 2.5 mg and 5 mg, and $329/month for doses between 7.5 mg and 15 mg. This two-tier model reflects different compound concentrations or vial sizes. PlexusDx uses a single flat rate ($289/month month-to-month) at every tirzepatide dose, which eliminates a mid-treatment price increase.
Can I switch from month-to-month to a commitment plan at PlexusDx?
PlexusDx offers month-to-month, 3-month, and 6-month billing options. Policy on mid-cycle plan changes is not detailed in the captured sources; contact PlexusDx support to confirm whether you can move from monthly to a commitment tier or vice versa after your initial order.
Does either provider offer brand-name Wegovy or Zepbound?
No. Both Amble and PlexusDx dispense compounded semaglutide and tirzepatide, which are not FDA-approved and differ from brand-name Wegovy, Ozempic, Mounjaro, or Zepbound. A licensed clinician determines whether a compounded prescription is appropriate for you.
How do I confirm Amble's pricing at checkout?
The pricing in this comparison was captured from Amble's published FAQ on September 4, 2026, and represents the provider's advertised rates. Because the figures were not validated during a live checkout session, you should complete Amble's intake process and review the final order summary before payment to confirm the current rate, dose tier, and any terms or conditions.
Sources
- PlexusDx semaglutide and tirzepatide product pages and pricing (plexusdx.com; accessed July 17–23, 2026, and September 10, 2026)
- Amble pricing FAQ (hosted on Canva; accessed September 4, 2026)
- PlexusDx Trustpilot profile (trustpilot.com/review/plexusdx.com; accessed September 9, 2026)
Ready to explore flat-rate GLP-1 with transparent monthly pricing?
One all-inclusive price covers your online provider visit, prescription, medication, and shipping—no membership, no hidden fees. Complete a short intake and a licensed provider reviews your fit.
Start My Intake →
Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Levity Pricing: Ozempic, Mounjaro & Wegovy Costs Compared 2026
Rex MD vs Ro: Wegovy Pill Programs Compared Head-to-Head in 2026